Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica Ollmann Saphire

Showing results (111-120 of 215) with videos related to

Pageof 22
Sort By:
Plos Pathogens|February 4, 2021
Evidence for distinct mechanisms of small molecule inhibitors of filovirus entryAdam Schafer, Rui Xiong, Laura Cooper, et al.
Nature Communications|July 2, 2025
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn virusesMichelle Meyer, Bronwyn M Gunn, Colette Pietzsch, et al.
Plos Pathogens|July 21, 2022
Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concernGonzalo Almanza, Alex E Clark, Valentina Kouznetsova, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Antigenic landscape of rabies and related lyssaviruses revealed by cryo-EMHeather M Callaway, Dawid S Zyla, Kathryn M Hastie, et al.
JCI Insight|February 23, 2026
SARS-CoV-2 antibody-dependent enhancement of infection depends on antibody binding to both ACE2 and Fc receptorsNatalia A Kuzmina, Sivakumar Periasamy, Kritika Kedarinath, et al.
Plos Pathogens|October 3, 2012
Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonismShridhar Bale, Jean-Philippe Julien, Zachary A Bornholdt, et al.
Journal of Molecular Biology|April 21, 2007
Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodiesErica Ollmann Saphire, Marinieve Montero, Alfredo Menendez, et al.
Mbio|June 22, 2022
Neutralizing Antibodies against Lassa Virus Lineage ITierra K Buck, Adrian S Enriquez, Sharon L Schendel, et al.
Cell Reports|May 25, 2022
Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodiesAdrian S Enriquez, Tierra K Buck, Haoyang Li, et al.
Advances in Experimental Medicine and Biology|January 13, 2004
Crystal structure of an intact human IgG: antibody asymmetry, flexibility, and a guide for HIV-1 vaccine designErica Ollmann Saphire, Robyn L Stanfield, M D Max Crispin, et al.
Pageof 22

Showing results (111-120 of 215) with videos related to

Sort By:
Pageof 22
Plos Pathogens|February 4, 2021
Evidence for distinct mechanisms of small molecule inhibitors of filovirus entryAdam Schafer, Rui Xiong, Laura Cooper, et al.
Nature Communications|July 2, 2025
Divergent antibody recognition profiles are generated by protective mRNA vaccines against Marburg and Ravn virusesMichelle Meyer, Bronwyn M Gunn, Colette Pietzsch, et al.
Plos Pathogens|July 21, 2022
Structure-selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concernGonzalo Almanza, Alex E Clark, Valentina Kouznetsova, et al.
Biorxiv : the Preprint Server for Biology|February 6, 2026
Antigenic landscape of rabies and related lyssaviruses revealed by cryo-EMHeather M Callaway, Dawid S Zyla, Kathryn M Hastie, et al.
JCI Insight|February 23, 2026
SARS-CoV-2 antibody-dependent enhancement of infection depends on antibody binding to both ACE2 and Fc receptorsNatalia A Kuzmina, Sivakumar Periasamy, Kritika Kedarinath, et al.
Plos Pathogens|October 3, 2012
Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonismShridhar Bale, Jean-Philippe Julien, Zachary A Bornholdt, et al.
Journal of Molecular Biology|April 21, 2007
Structure of a high-affinity "mimotope" peptide bound to HIV-1-neutralizing antibody b12 explains its inability to elicit gp120 cross-reactive antibodiesErica Ollmann Saphire, Marinieve Montero, Alfredo Menendez, et al.
Mbio|June 22, 2022
Neutralizing Antibodies against Lassa Virus Lineage ITierra K Buck, Adrian S Enriquez, Sharon L Schendel, et al.
Cell Reports|May 25, 2022
Delineating the mechanism of anti-Lassa virus GPC-A neutralizing antibodiesAdrian S Enriquez, Tierra K Buck, Haoyang Li, et al.
Advances in Experimental Medicine and Biology|January 13, 2004
Crystal structure of an intact human IgG: antibody asymmetry, flexibility, and a guide for HIV-1 vaccine designErica Ollmann Saphire, Robyn L Stanfield, M D Max Crispin, et al.
Pageof 22